Ubicept, the revolutionary computer vision technology company, announced it has secured $8M in funding. The oversubscribed seed investment round was led by Ubiquity Ventures and E14 Fund, with participation from Wisconsin Alumni Research Foundation, Phoenix Venture Partners (PVP), and several other investors and angel contributors.
Born out of the world-class labs of MIT and University of Wisconsin-Madison, Ubicept is redefining boundaries in the field of computer vision. Traditional computer vision relies on a dated “still frame” approach, whereas Ubicept bypasses this old logic and directly leverages single-photon sensors to turn the individual photons that hit an imaging sensor into a reliable computer vision output. The resulting perception system can operate in extreme lighting conditions, capture sharp images of high-speed motion, and even “see” around corners. Ubicept targets a price point similar to conventional camera systems.
“We are excited about this major milestone. This funding will allow us to accelerate our efforts to transform the way computers ‘see’ and understand the world, especially in challenging environments,” said Sebastian Bauer, co-founder and CEO.
“Ubicept is the first company in the world with this “count individual photons” approach to computer vision. I see tremendous demand right now for this next generation of perception and the use cases it unlocks,” said Sunil Nagaraj of Ubiquity Venture. Mr. Nagaraj has also joined the Ubicept Board of Directors.
Habib Haddad, Managing Partner of E14 Fund, adds: “The development in the market for single-photon sensors has picked up dramatically in the last few years, with smartphone manufacturers adding them to their devices for depth sensing. The processing Ubicept adds to such sensor type will enable their widespread use for general-purpose imaging and a wide array of computer vision applications. The output quality is so much better than what conventional sensors provide.” The new capital will be used to expand the Ubicept team, secure further intellectual property rights, and bring their product to more customers across several industries. This investment will strengthen Ubicept’s position as the leader in single-photon computer vision.